Targeting potential drivers of COVID-19: Neutrophil extracellular traps BJ Barnes, JM Adrover, A Baxter-Stoltzfus, A Borczuk, J Cools-Lartigue, ... Journal of Experimental Medicine 217 (6), 2020 | 1560 | 2020 |
Neutrophil extracellular traps in COVID-19 Y Zuo, S Yalavarthi, H Shi, K Gockman, M Zuo, JA Madison, W Woodard, ... JCI Insight 5 (11), 2020 | 1502 | 2020 |
Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19 Y Zuo, SK Estes, RA Ali, AA Gandhi, S Yalavarthi, H Shi, G Sule, ... Science translational medicine 12 (570), eabd3876, 2020 | 616 | 2020 |
Neutrophil extracellular traps and thrombosis in COVID-19 Y Zuo, M Zuo, S Yalavarthi, K Gockman, JA Madison, H Shi, W Woodard, ... Journal of Thrombosis and Thrombolysis 51, 446-453, 2021 | 288 | 2021 |
Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients Y Zuo, M Warnock, A Harbaugh, S Yalavarthi, K Gockman, M Zuo, ... Scientific reports 11 (1), 1580, 2021 | 226 | 2021 |
Neutrophil calprotectin identifies severe pulmonary disease in COVID-19 H Shi, Y Zuo, S Yalavarthi, K Gockman, M Zuo, JA Madison, C Blair, ... Journal of Leucocyte Biology 109 (1), 67-72, 2021 | 137 | 2021 |
Efficient, long-term hepatic gene transfer using clinically relevant HDAd doses by balloon occlusion catheter delivery in nonhuman primates N Brunetti-Pierri, GE Stapleton, M Law, J Breinholt, DJ Palmer, Y Zuo, ... Molecular Therapy 17 (2), 327-333, 2009 | 103 | 2009 |
Pseudo-hydrodynamic delivery of helper-dependent adenoviral vectors into non-human primates for liver-directed gene therapy N Brunetti-Pierri, GE Stapleton, DJ Palmer, Y Zuo, VP Mane, MJ Finegold, ... Molecular Therapy 15 (4), 732-740, 2007 | 97 | 2007 |
Endothelial cell–activating antibodies in COVID‐19 H Shi, Y Zuo, S Navaz, A Harbaugh, CK Hoy, AA Gandhi, G Sule, ... Arthritis & Rheumatology 74 (7), 1132-1138, 2022 | 87 | 2022 |
Autoantibodies stabilize neutrophil extracellular traps in COVID-19 Y Zuo, S Yalavarthi, SA Navaz, CK Hoy, A Harbaugh, K Gockman, M Zuo, ... JCI insight 6 (15), 2021 | 75 | 2021 |
Anti–neutrophil extracellular trap antibodies and impaired neutrophil extracellular trap degradation in antiphospholipid syndrome Y Zuo, S Yalavarthi, K Gockman, JA Madison, JE Gudjonsson, ... Arthritis & Rheumatology 72 (12), 2130-2135, 2020 | 70 | 2020 |
Prothrombotic antiphospholipid antibodies in COVID-19 Y Zuo, SK Estes, RA Ali, AA Gandhi, S Yalavarthi, H Shi, G Sule, ... MedRxiv, 2020.06. 15.20131607, 2020 | 50 | 2020 |
Neutrophil extracellular traps in COVID-19. JCI Insight. 2020 Y Zuo, S Yalavarthi, H Shi, K Gockman, M Zuo, JA Madison, C Blair, ... Article e138999 View in Scopus, 0 | 46 | |
Pediatric antiphospholipid syndrome JA Madison, Y Zuo, JS Knight European Journal of Rheumatology 7 (Suppl 1), S3, 2020 | 45 | 2020 |
The interplay between neutrophils, complement, and microthrombi in COVID-19 Y Zuo, Y Kanthi, JS Knight, AHJ Kim Best practice & research Clinical rheumatology 35 (1), 101661, 2021 | 42 | 2021 |
New (re) purpose for an old drug: purinergic modulation may extinguish the COVID-19 thromboinflammatory firestorm Y Kanthi, JS Knight, Y Zuo, DJ Pinsky JCI insight 5 (14), 2020 | 41 | 2020 |
Bioengineered factor IX molecules with increased catalytic activity improve the therapeutic index of gene therapy vectors for hemophilia B N Brunetti-Pierri, NC Grove, Y Zuo, R Edwards, D Palmer, V Cerullo, ... Human gene therapy 20 (5), 479-485, 2009 | 40 | 2009 |
Antiphospholipid syndrome: a clinical perspective Y Zuo, H Shi, C Li, JS Knight Chinese Medical Journal 133 (08), 929-940, 2020 | 39 | 2020 |
Neutrophil extracellular traps in COVID-19. JCI Insight. 2020; 5 (11): e138999 Y Zuo, S Yalavarthi, H Shi, K Gockman, M Zuo, JA Madison, CN Blair, ... Go to original source, 0 | 29 | |
Primary thrombosis prophylaxis in persistently antiphospholipid antibody-positive individuals: where do we stand in 2018? Y Zuo, M Barbhaiya, D Erkan Current Rheumatology Reports 20, 1-12, 2018 | 25 | 2018 |